Author

Julie Bauman

Institution: University of Arizona Cancer Center

Observed institution: University of Arizona Cancer Center

OpenAlex ID: A5146753208

Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet)

2026 · Ajay Bansal, Elena M. Stoffel, et al. · Frontiers in Immunology

Works count: 1

Citation count:

H-index:

I10-index: